Although increased levels of sST2 in patients with STEMI and NSTEMI were shown over different periods of time [6], [11], [13], [14], a comparison of sST2 and IL-33 concentrations in patients with stable angina and acute coronary syndromes and individuals without CAD was not studied before and was the aim of our study. This evidence concerns the gene IL33 and acute coronary syndrome.